Maropitant Citrate Tablet
NDC Package 85209-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Maropitant Citrate tablets is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a tablet delivery system. Marketed by Hong Kong Xile International Trading Limited, this product is identified by NDC 85209-002.

Identification & Billing

NDC Package Code
85209-002-01
Package Description
10 CAPSULE in 1 BOX / 16 mg in 1 CAPSULE
Product Code
85209-002
11-Digit Billing Format
85209000201

Clinical Specifications

Proprietary Name
Maropitant Citrate
Non-Proprietary Name
Maropitant Citrate
Substance Name
Maropitant Citrate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Active Ingredient(s)
MAROPITANT CITRATE 16 mg/16mg

Regulatory & Marketing

Labeler Name
Hong Kong Xile International Trading Limited
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
04-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85209-002-01 identifies a specific commercial package of 10 capsule in 1 box / 16 mg in 1 capsule of Maropitant Citrate (UNFINISHED drug), a bulk ingredient labeled by Hong Kong Xile International Trading Limited. This tablet is formulated for use and contains maropitant citrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hong Kong Xile International Trading Limited on April 01, 2025. The current certification is valid through December 31, 2026.

How is this Hong Kong Xile International Trading Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85209000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85209-002-01
11-Digit CMS (5-4-2)
85209-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.